BioPharma, Pharma Harvard spinout Surge emerges with $26M to make immunotherapy part of cancer surgery By Frank Vinluan
BioPharma, Pharma Harvard spinout lands $40M to bring in vivo drug discovery to cancer By Frank Vinluan
BioPharma, Pharma, Artificial Intelligence Harvard spinout Nabla Bio lands $11M to bring AI technology to antibody design By Frank Vinluan
BioPharma, Pharma Resilience turns to Harvard for biologics manufacturing tech, inks 5-year R&D pact By Frank Vinluan
Health IT, Patient Engagement Harvard Health and Outcome Health are delivering more expertise to the doctor’s office By Erin Dietsche
BioPharma, Startups Harvard University spinout raises $10M to advance platelet bioreactor technology By Josh Baxt
Startups, Diagnostics Harvard spinout’s test gauges HIV drug resistance using qPCR By Meghana Keshavan
Top Story Morning Read: Valeant loses $6 billion in value, the digital health drumbeat hits Harvard By Chris Seper
Health IT Case, UCLA, Harvard look to data provenance to reconcile multiple sources of big data By Neil Versel
Kaiser Harvard Medical School study finds symptom checker websites unreliable By Martha Bebinger, WBUR
Top Story, Hospitals Harvard Medical School Professor Ted Kaptchuk: How placebo studies are changing the art of medicine By
